{"AllianceGenome": "2330", "HGNC": "2330", "MIM": "600650", "_id": "1376", "_version": 1, "accession": {"genomic": ["AH005331.2", "AL606760.9", "CH471059.2", "CP068277.2", "CQ789417.1", "HC892329.1", "HC898236.1", "HC901564.1", "NC_000001.11", "NC_060925.1", "NG_008035.1", "X78707.1"], "protein": ["AAB59462.1", "AAB60382.1", "AAB60383.1", "AAH02445.1", "AAH05172.1", "AEE61150.1", "BAD96772.1", "BAG35567.1", "CAA55360.1", "CAG24446.1", "CBN60633.1", "CBN63525.1", "CBN65242.1", "EAX06753.1", "NP_000089.1", "NP_001317518.1", "P23786.2"], "rna": ["AK223052.1", "AK312687.1", "BC002445.2", "BC005172.2", "BU629852.1", "HM005553.1", "M58581.1", "NM_000098.3", "NM_001330589.2", "U09648.1"], "translation": [{"protein": "BAD96772.1", "rna": "AK223052.1"}, {"protein": "NP_001317518.1", "rna": "NM_001330589.2"}, {"protein": "NP_000089.1", "rna": "NM_000098.3"}, {"protein": "AEE61150.1", "rna": "HM005553.1"}, {"protein": "BAG35567.1", "rna": "AK312687.1"}, {"protein": "AAB60383.1", "rna": "U09648.1"}, {"protein": "AAH02445.1", "rna": "BC002445.2"}, {"protein": "AAB59462.1", "rna": "M58581.1"}, {"protein": "AAH05172.1", "rna": "BC005172.2"}]}, "alias": ["CPT1", "CPTASE", "IIAE4"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2018-03-27T16:00:00.000Z", "disease_label": "carnitine palmitoyltransferase II deficiency", "gcep": "Fatty Acid Oxidation Disorders Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0015515", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a57ea10-6ca0-4311-94f1-0ad036a38ca6-2018-03-27T160000.000Z", "sop": "SOP6"}}, "ec": "2.3.1.21", "ensembl": {"gene": "ENSG00000157184", "protein": ["ENSP00000360541", "ENSP00000489631", "ENSP00000489756", "ENSP00000489757", "ENSP00000490042", "ENSP00000490066", "ENSP00000490399", "ENSP00000490492", "ENSP00000490867"], "transcript": ["ENST00000371486", "ENST00000468572", "ENST00000635862", "ENST00000635888", "ENST00000636239", "ENST00000636673", "ENST00000636867", "ENST00000636891", "ENST00000636935", "ENST00000637252", "ENST00000637726", "ENST00000638135"], "translation": [{"protein": "ENSP00000360541", "rna": "ENST00000371486"}, {"protein": "ENSP00000489631", "rna": "ENST00000636867"}, {"protein": "ENSP00000490066", "rna": "ENST00000636239"}, {"protein": "ENSP00000490399", "rna": "ENST00000636891"}, {"protein": "ENSP00000490492", "rna": "ENST00000637252"}, {"protein": "ENSP00000489757", "rna": "ENST00000636935"}, {"protein": "ENSP00000490867", "rna": "ENST00000635862"}, {"protein": "ENSP00000490042", "rna": "ENST00000635888"}, {"protein": "ENSP00000489756", "rna": "ENST00000638135"}], "type_of_gene": "protein_coding"}, "entrezgene": "1376", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 13.3610900274, "exp_mis": 212.636725881, "exp_syn": 91.8888425215, "lof_z": 0.639854617100142, "mis_z": -0.448240469849076, "mu_lof": 1.07282162359e-06, "mu_mis": 2.06236722959e-05, "mu_syn": 8.87072831551e-06, "n_lof": 11.0, "n_mis": 226.0, "n_syn": 115.0, "p_li": 4.77178075381137e-07, "p_null": 0.608045434344952, "p_rec": 0.391954088476973, "syn_z": -1.49465113241268}, "bp": 1977, "cds_end": 53679267, "cds_start": 53662615, "n_exons": 5, "nonpsych": {"exp_lof": 12.004279589, "exp_mis": 192.367965465, "exp_syn": 83.0794766134, "lof_z": 1.41848734733014, "mis_z": -0.532106930115884, "mu_lof": 1.07282162359e-06, "mu_mis": 2.06236722959e-05, "mu_syn": 8.87072831551e-06, "n_lof": 7.0, "n_mis": 207.0, "n_syn": 102.0, "p_li": 0.000535162222662795, "p_null": 0.129046181368606, "p_rec": 0.870418656408731, "syn_z": -1.30692202763399}, "nontcga": {"exp_lof": 12.2835481479, "exp_mis": 195.617147111, "exp_syn": 84.5290869677, "lof_z": 0.36126960293922, "mis_z": -0.191742713449109, "mu_lof": 1.07282162359e-06, "mu_mis": 2.06236722959e-05, "mu_syn": 8.87072831551e-06, "n_lof": 11.0, "n_mis": 201.0, "n_syn": 111.0, "p_li": 2.35118582453969e-07, "p_null": 0.722564174130519, "p_rec": 0.277435590750898, "syn_z": -1.82300585867532}, "transcript": "ENST00000371486.3"}, "exons": [{"cdsend": 53213595, "cdsstart": 53196943, "chr": "1", "position": [[53196823, 53197095], [53200718, 53200799], [53202322, 53202429], [53210014, 53211319], [53213263, 53214197]], "strand": 1, "transcript": "NM_000098", "txend": 53214197, "txstart": 53196823}, {"cdsend": 53213595, "cdsstart": 53196943, "chr": "1", "position": [[53196823, 53197095], [53200718, 53200799], [53202322, 53202429], [53210014, 53211250], [53213263, 53214197]], "strand": 1, "transcript": "NM_001330589", "txend": 53214197, "txstart": 53196823}], "exons_hg19": [{"cdsend": 53679267, "cdsstart": 53662615, "chr": "1", "position": [[53662495, 53662767], [53666390, 53666471], [53667994, 53668101], [53675686, 53676991], [53678935, 53679869]], "strand": 1, "transcript": "NM_000098", "txend": 53679869, "txstart": 53662495}, {"cdsend": 53679267, "cdsstart": 53662615, "chr": "1", "position": [[53662495, 53662767], [53666390, 53666471], [53667994, 53668101], [53675686, 53676922], [53678935, 53679869]], "strand": 1, "transcript": "NM_001330589", "txend": 53679869, "txstart": 53662495}], "generif": [{"pubmed": 11001805, "text": "Human CPT1A, CPT1B, CPT2, CROT and CRAT are known to encode active carnitine acyltransferases.  Earlier pfam annotations refer to the non-existing compound CARNITATE.  In 2000 this has been changed to CARNITINE."}, {"pubmed": 11855939, "text": "New allele (515del14)leads to a frameshift that results in a stop codon 15 codons upstream."}, {"pubmed": 11994355, "text": "genetic CPT II deficiency is characterized by insulin resistance, which is not explained by increased intramyomellular lipids.  Homozygote."}, {"pubmed": 12408750, "text": "5'-flanking region of this gene is transcriptionally active and binds PPARalpha , we characterized the peroxisome proliferator-responsive element in the proximal promoter of the CPT II gene, which appears to be a novel PPRE."}, {"pubmed": 12707442, "text": "3 described mutations (S113L, P50H, & F448L) & two novel mutations (M214T & Y479F)OF cpt2 were modeled. A structure could be identified anchoring the protein in the membrane. Only Y479F is located within this region."}, {"pubmed": 12971426, "text": "Very high activity of CPT2 and VCLAD, involved in the metabolism of long-chain fatty acids. Fatty acid oxidation may play role in energy generation in placenta, and deficiency in may result in placental dysfunction and gestational complications."}, {"pubmed": 15622536, "text": "These results indicate that mutation of CPT II patient not to increase fatty acid oxidation during exercise. And also suggest that single CPT2 gene mutations may exert a dominant-negative effect on the tetrameric CPT II protein."}, {"pubmed": 15642848, "text": "The phenotype of muscle CPT II deficiency might be influenced by the underlying mutation,analysis of S113L ,P50H and Q413fs-F448L mutations"}, {"pubmed": 15647998, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15754283, "text": "A novel variant of CPT II was found in a patient with rhabdomyolysis & acute renal failure: a deletion of cytosine & thymine at codon 408, resulting in a stop signal at 420, & an Arg631Cys mutation. The frame shift at 408 has never been described before."}, {"pubmed": 16168441, "text": "A patient had an episode of acute renal failure with myoglobinuria, myalgias, and weakness.  Carnitine palmitoyl-transferase II (CPT II) deficiency was documented both biochemically and genetically."}, {"pubmed": 16670153, "text": "In conclusion, the findings from this study indicate that exercise training alters the localization of FAT/CD36 and increases its association with CPT I, which may help augment fat oxidation."}, {"pubmed": 16671104, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16996287, "text": "Within the CPT2 gene there were identified 16 novel deasese-causing mutations."}, {"pubmed": 17179390, "text": "acute overexpression of CPT I in muscle leads to a repartitioning of FAs away from esterification and toward oxidation and highlight the importance of CPT I in regulating muscle fatty acid metabolism."}, {"pubmed": 17651973, "text": "Our data evidenced that R631C mutation is not exclusively detected in the infantile form but it may be present in a wider spectrum of CPT2 phenotypes. These findings suggest that other modulators may influence clinical severity of CPT2 deficiency."}, {"pubmed": 17709715, "text": "We report a Japanese adult form of CPT II deficiency associated with a homozygous F383Y mutation causing myalgia and rhabdomyolysis."}, {"pubmed": 17936304, "text": "our data expand the spectrum of CPT II mutations and help to evaluate possible correlations between genotypes and phenotypes"}, {"pubmed": 18024217, "text": "It was not possible to repair the CPT-2 gene under a variety of conditions, this approach is of little value until cellular DNA repair mechanisms are much better understood."}, {"pubmed": 18306170, "text": "unstable CPT II variants with decreased enzymatic activity may bring mitochondrial fuel utilization below the phenotypic threshold during high fever, and thus may play an important role in development of brain edema of influenza-associated encephalopathy"}, {"pubmed": 18363739, "text": "study identified p.F383Y mutations in 6 of 7 Japanese patients with CPT II deficiency & 2 novel variants of the coding gene: p.Y408fsX420 & p.V605L; data suggest that the p.F383Y mutation is significant in Japanese patients with CPT II deficiency"}, {"pubmed": 18550408, "text": "Two mutations in the CPT2 gene were identified in lethal neonatal or severe infantile diseases."}, {"pubmed": 18645163, "text": "The triheptanoin diet seems to be an effective therapy for adult-onset carnitine palmitoyltransferase II deficiency."}, {"pubmed": 18996102, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19362304, "text": "Patient with adult-onset carnitine palmitoyl transferase II deficiency was able to have a successful pregnancy outcomes after fertilization in vitro."}, {"pubmed": 19762733, "text": "Case Report: Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20370797, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20602615, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20810031, "text": "We found a high frequency of the common p.Ser113Leu mutation, the recurrence of the rare p.Arg631Cys mutation , and identified four novel mutations, in patients with muscle type CPT II deficiency."}, {"pubmed": 20877624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20934285, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20934285, "text": "Results revealed that having at least one carnitine palmitoyl transferase II CIM allele is a risk factor for the onset of acute encephalopathy, regardless of its antecedent infections."}, {"pubmed": 20952238, "text": "Analyzed potential rhabdomyolysis-susceptibility genes (RYR 1, CPT II, VLCAD and CYP 2D6) from autopsy samples of methamphetamine abusers; no obvious relationship between the genetic mutations observed in this study and rhabdomyolysis was seen."}, {"pubmed": 21277129, "text": "the thermolabile F352C CPT II variant, found only in Japanese, might be one of the predisposing factors to trigger the pathomechanism of acute encephalopathy in the Japanese population"}, {"pubmed": 21641254, "text": "A homozygous mutation (c.534_558del25bpinsT) of CPT2 in a case of neonatal CPT II deficiency associated with Dandy-Walker syndrome and sudden death at 13 days of life."}, {"pubmed": 21697855, "text": "Data demonstrated the thermolabile CPT-II variants in demonstrated the thermolabile CPT-II variants in patients with viral infection-associated encephalopathy in Chinese population."}, {"pubmed": 21913903, "text": "Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency"}, {"pubmed": 23322164, "text": "CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mitochondrial fatty acid beta-oxidation disorders."}, {"pubmed": 23475205, "text": "The present study shows that screening for second mutations in patients that are heterozygote for the common p.S113L is justified although rare symptomatic heterozygotes."}, {"pubmed": 23566841, "text": "The homozygous genotype (AA) of CPT2 variant V368I had significantly less blood carnitine in acute myocardial infarction patients."}, {"pubmed": 23969168, "text": "The F352C CPT2 variant might be a genetic risk factor for sudden unexpected death in infancy"}, {"pubmed": 24398345, "text": "The data indicate that within the muscle form of CPT II deficiency, the various genotypes have only marginal influence on the clinical and biochemical phenotype."}, {"pubmed": 25335471, "text": "L-carnitine deficiency participates in the pathogenesis of endometrial cancer by means of a mechanism which is unrelated with obesity and increased amount of fat in human body."}, {"pubmed": 25361188, "text": "The rs2229291 and rs1799821 variants in CPT II gene might be one of the predisposing factors of acute encephalitis."}, {"pubmed": 25781464, "text": "CPT II deficiency induces an energy crisis of the fatty acid metabolic pathway."}, {"pubmed": 26041663, "text": "CPT2 is active inside the mitochondrial matrix to recover acyl-CoA from a process generally known as the carnitine shuttle. This protein is expressed in a constitutive way in all cells and tissues."}, {"pubmed": 26874509, "text": "polymorphism may be associated with severity of EV71 infection"}, {"pubmed": 27034144, "text": "To the best of our knowledge, this is the first report of the coexistence of VHL disease and CPT2 deficiency in the same individual. Based on findings from animal models, the case illustrates that mutations in the VHL gene might protect against renal damage caused by CPT2 gene mutations."}, {"pubmed": 27502741, "text": "this study shows that upregulation of the citrate pathway and down-regulation of carnitine/acylcarnitine carrier gene in cells from children with Down syndrome"}, {"pubmed": 27525900, "text": "Variations in AMPD1, CPT2, and PGYM genes are not associated with the onset, susceptibility, or severity of chronic fatigue syndrome."}, {"pubmed": 28054946, "text": "The clinical presentation of patients with muscle carnitine palmitoyltransferase II deficiency is discussed in this review in line with enzymatic features. The thermolability of the mutant enzyme might explain why symptoms in muscle CPT II deficiency mainly occur during prolonged exercise, infections and exposure to cold.  [review]"}, {"pubmed": 30007356, "text": "The results show that AMPK activation by GSK773 evokes the slow, oxidative myogenic program and triggers beneficial phenotypic adaptations in FAO-deficient myotubes. Thus, GSK773 might have therapeutic potential for correction of CPT2 deficiency"}, {"pubmed": 30604089, "text": "Lack of activation of the S113L variant of carnitine palmitoyltransfersase II by cardiolipin."}, {"pubmed": 31151054, "text": "We used metabolomics to demonstrate that inhibition of CDK9 leads to accumulation of acyl-carnitines, metabolic intermediates in fatty acid oxidation (FAO). Acyl-carnitines are produced by carnitine palmitoyltransferase enzymes 1 and 2 (CPT), and we used both genetic and pharmacological tools to show that inhibition of CPT-activity is synthetically lethal with CDK9 inhibition"}, {"pubmed": 31201655, "text": "rs1799822 in the CPT2 gene is associated with the severity of EV71 encephalitis in Chinese children."}, {"pubmed": 31351739, "text": "in 416 patients of acute encephalopathy, including both severe and mild syndrome, minor allele frequency of rs2229291 was significantly higher in acute encephalopathy with biphasic seizures (p=0.044), MERS (p=0.015) and entire acute encephalopathy (p=0.044) compared to the controls."}, {"pubmed": 31599017, "text": "Carnitine palmitoyltransferase II deficiency in a prenatal case with polycystic kidney disease-like phenotype."}, {"pubmed": 32848104, "text": "Kinetics of Serum Carnitine Fractions in Patients with Chronic Kidney Disease Not on Dialysis."}, {"pubmed": 33207079, "text": "HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer."}, {"pubmed": 34020866, "text": "Successful orthotopic heart transplantation in CPTII deficiency."}, {"pubmed": 34626609, "text": "Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia."}, {"pubmed": 35108639, "text": "Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer."}, {"pubmed": 36195841, "text": "Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer."}, {"pubmed": 37926998, "text": "SGMS1-AS1/MicroRNA-106a-5p/CPT2 Axis as a Novel Target for Regulating Lactate Metabolism in Colon Cancer."}, {"pubmed": 37950149, "text": "Role of PPAR-related genes in chronic heart failure: evidence from large populations."}, {"pubmed": 38395422, "text": "Myopathy due to carnitine palmitoyltransferase II deficiency: updating genetic aspects of the first publication in Brazil."}, {"pubmed": 38428407, "text": "GBA3 promotes fatty acid oxidation and alleviates non-alcoholic fatty liver by increasing CPT2 transcription."}], "genomic_pos": {"chr": "1", "end": 53214197, "ensemblgene": "ENSG00000157184", "start": 53196792, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 53679869, "start": 53662101, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0001676", "pubmed": 20538056, "qualifier": "involved_in", "term": "long-chain fatty acid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001701", "qualifier": "involved_in", "term": "in utero embryonic development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006635", "qualifier": "involved_in", "term": "fatty acid beta-oxidation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006635", "pubmed": 20538056, "qualifier": "involved_in", "term": "fatty acid beta-oxidation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006635", "qualifier": "involved_in", "term": "fatty acid beta-oxidation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006853", "qualifier": "involved_in", "term": "carnitine shuttle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009437", "pubmed": 20538056, "qualifier": "involved_in", "term": "carnitine metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0120162", "pubmed": 25578732, "qualifier": "involved_in", "term": "positive regulation of cold-induced thermogenesis"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "is_active_in", "term": "mitochondrion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005743", "pubmed": 1988962, "qualifier": "located_in", "term": "mitochondrial inner membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005743", "qualifier": "located_in", "term": "mitochondrial inner membrane"}], "MF": [{"category": "MF", "evidence": "EXP", "id": "GO:0004095", "pubmed": 7711730, "qualifier": "enables", "term": "carnitine O-palmitoyltransferase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004095", "qualifier": "enables", "term": "carnitine O-palmitoyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004095", "pubmed": 20538056, "qualifier": "enables", "term": "carnitine O-palmitoyltransferase activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0004095", "pubmed": 1988962, "qualifier": "enables", "term": "carnitine O-palmitoyltransferase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0008458", "qualifier": "enables", "term": "carnitine O-octanoyltransferase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016746", "pubmed": 20538056, "qualifier": "enables", "term": "acyltransferase activity"}]}, "homologene": {"genes": [[4932, 851285], [5141, 3872670], [6239, 178025], [7165, 1279874], [7227, 38355], [7955, 100005717], [8364, 394801], [9031, 424649], [9544, 714150], [9598, 737945], [9606, 1376], [9615, 489585], [9913, 504502], [10090, 12896], [10116, 25413], [28985, 2892029], [33169, 4621291], [318829, 2685154]], "id": 77}, "interpro": [{"desc": "Acyltransferase ChoActase/COT/CPT", "id": "IPR000542", "short_desc": "Carn_acyl_trans"}, {"desc": "Chloramphenicol acetyltransferase-like domain superfamily", "id": "IPR023213", "short_desc": "CAT-like_dom_sf"}, {"desc": "Choline/carnitine acyltransferase domain", "id": "IPR039551", "short_desc": "Cho/carn_acyl_trans"}, {"desc": "Choline/Carnitine o-acyltransferase, domain 2", "id": "IPR042231", "short_desc": "Cho/carn_acyl_trans_2"}, {"desc": "Carnitine o-acyltransferase, N-terminal", "id": "IPR042572", "short_desc": "Carn_acyl_trans_N"}], "ipi": "IPI00012912", "map_location": "1p32.3", "name": "carnitine palmitoyltransferase 2", "other_names": ["CPT II", "carnitine O-palmitoyltransferase 2, mitochondrial", "carnitine palmitoyltransferase II", "testicular secretory protein Li 13"], "pantherdb": {"HGNC": "2330", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "109176", "ortholog_type": "LDO", "panther_family": "PTHR22589", "taxid": 10090, "uniprot_kb": "P52825"}, {"RGD": "2398", "ortholog_type": "LDO", "panther_family": "PTHR22589", "taxid": 10116, "uniprot_kb": "P18886"}, {"Ensembl": "ENSGALG00000010681", "ortholog_type": "LDO", "panther_family": "PTHR22589", "taxid": 9031, "uniprot_kb": "F1P1U3"}, {"ZFIN": "ZDB-GENE-030131-6719", "ortholog_type": "LDO", "panther_family": "PTHR22589", "taxid": 7955, "uniprot_kb": "Q5U3U3"}, {"WormBase": "WBGene00011122", "ortholog_type": "LDO", "panther_family": "PTHR22589", "taxid": 6239, "uniprot_kb": "G5ECS9"}, {"FlyBase": "FBgn0035383", "ortholog_type": "LDO", "panther_family": "PTHR22589", "taxid": 7227, "uniprot_kb": "Q9VZW7"}], "uniprot_kb": "P23786"}, "pathway": {"humancyc": {"id": "PWY-6111", "name": "mitochondrial L-carnitine shuttle"}, "kegg": [{"id": "hsa00071", "name": "Fatty acid degradation - Homo sapiens (human)"}, {"id": "hsa03320", "name": "PPAR signaling pathway - Homo sapiens (human)"}, {"id": "hsa04714", "name": "Thermogenesis - Homo sapiens (human)"}, {"id": "hsa05415", "name": "Diabetic cardiomyopathy - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1989781", "name": "PPARA activates gene expression"}, {"id": "R-HSA-200425", "name": "Carnitine metabolism"}, {"id": "R-HSA-400206", "name": "Regulation of lipid metabolism by PPARalpha"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8978868", "name": "Fatty acid metabolism"}], "smpdb": [{"id": "SMP00030", "name": "Oxidation of Branched Chain Fatty Acids"}, {"id": "SMP00051", "name": "Fatty acid Metabolism"}, {"id": "SMP00052", "name": "Beta Oxidation of Very Long Chain Fatty Acids"}, {"id": "SMP00181", "name": "Ethylmalonic Encephalopathy"}, {"id": "SMP00185", "name": "Glutaric Aciduria Type I"}, {"id": "SMP00235", "name": "Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)"}, {"id": "SMP00482", "name": "Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids"}, {"id": "SMP00516", "name": "Adrenoleukodystrophy, X-linked"}, {"id": "SMP00517", "name": "Carnitine-acylcarnitine translocase deficiency"}, {"id": "SMP00538", "name": "Carnitine palmitoyl transferase deficiency (I)"}, {"id": "SMP00539", "name": "Long chain acyl-CoA dehydrogenase deficiency (LCAD)"}, {"id": "SMP00540", "name": "Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)"}, {"id": "SMP00541", "name": "Carnitine palmitoyl transferase deficiency (II)"}, {"id": "SMP00542", "name": "Medium chain acyl-coa dehydrogenase deficiency (MCAD)"}, {"id": "SMP00545", "name": "Trifunctional protein deficiency"}], "wikipathways": [{"id": "WP143", "name": "Fatty acid beta-oxidation"}, {"id": "WP2878", "name": "PPAR-alpha pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP368", "name": "Mitochondrial LC-Fatty Acid Beta-Oxidation"}, {"id": "WP3942", "name": "PPAR signaling pathway"}, {"id": "WP4321", "name": "Thermogenesis"}]}, "pfam": "PF00755", "pharmgkb": "PA26849", "pharos": {"target_id": 10876, "tdl": "Tchem"}, "pir": "A39018", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF247851", "relationship": "is"}, {"id": "GNF247852", "relationship": "is"}, {"id": "GNF247853", "relationship": "is"}, {"id": "GNF247854", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF035408", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": {"id": "GNF083687", "relationship": "is"}, "GNF_hs-druggable_plasmid-shRNA": {"id": "GNF060824", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF002947", "relationship": "is"}, {"id": "GNF002948", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": [{"id": "GNF284998", "relationship": "is"}, {"id": "GNF285438", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094995", "relationship": "is"}, {"id": "GNF134652", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_008035.1"], "protein": ["NP_000089.1", "NP_001317518.1"], "rna": ["NM_000098.3", "NM_001330589.2"], "translation": [{"protein": "NP_001317518.1", "rna": "NM_001330589.2"}, {"protein": "NP_000089.1", "rna": "NM_000098.3"}]}, "reporter": {"HG-U133_Plus_2": ["204263_s_at", "204264_at"], "HTA-2_0": "TC01000651.hg.1", "HuEx-1_0": "2336706", "HuGene-1_1": "7901549", "HuGene-2_1": "16664852"}, "summary": "The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008].", "symbol": "CPT2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413690"}, "unigene": "Hs.713535", "uniprot": {"Swiss-Prot": "P23786", "TrEMBL": ["A0A140VK13", "A0A1B0GTB8", "A0A1B0GTM0", "A0A1B0GVF3", "A0A1B0GUD9", "A0A1B0GUB8", "A0A1B0GV75", "A0A1B0GWC0", "A0A1B0GTL9"]}, "wikipedia": {"url_stub": "Carnitine palmitoyltransferase II"}}